CREDIT FOR INCREASING RESEARCH ACTIVITIES (OR FOR CLAIMING THE ORPHAN DRUG CREDIT)

Forms and Documents

Document Name	Status

No forms / supporting documents in this ICR. Check IC Document Collections.

IC Document Collections

IC ID	Document Title	Status
130225	CREDIT FOR INCREASING RESEARCH ACTIVITIES (OR FOR CLAIMING THE ORPHAN DRUG CREDIT) Form	Migrated

ICR Details

OMB Control No: 1545-0619	ICR Reference No: 198708-1545-025
Status: Historical Active	Previous ICR Reference No: 198612-1545-029
Agency/Subagency: TREAS/IRS	Agency Tracking No:
Title: CREDIT FOR INCREASING RESEARCH ACTIVITIES (OR FOR CLAIMING THE ORPHAN DRUG CREDIT)
Type of Information Collection: Revision of a currently approved collection	Common Form ICR:  No
Type of Review Request: Regular
OIRA Conclusion Action: Approved without change	Conclusion Date: 10/19/1987
	Date Received in OIRA: 08/20/1987
Terms of Clearance: You may omit printing the expiration date on this form. Also, you may continue to use previous verions of this form.

	Inventory as of this Action	Requested	Previously Approved
Expiration Date	10/31/1990	10/31/1990	10/31/1989
Responses	15,000	0	17,000
Time Burden (Hours)	19,099	0	19,565
Cost Burden (Dollars)	0	0	0

---

Abstract: IRC SECTION 38 ALLOWS A CREDIT AGAINST INCOME TAX FOR AN INCREASE IN RESEARCH ACTIVITIES OF A TRADE OR BUSINE SECTION 28 ALLOWS A CREDIT FOR CLINICAL TESTING EXPENSES IN CONNECTION WITH DRUGS FOR CERTAIN RARE DISEASES. FORM 6765 IS USED BY BUSINESSES AND INDIVIDUALS ENGAGED IN A TRADE OR BUSINESS TO FIGURE AND REPORT TH CREDIT. THE DATA IS USED TO VERIFY THAT THE CREDIT CLAIMED IS CORRECT

---

Authorizing Statute(s): None

Citations for New Statutory Requirements: None

---

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:

---

Federal Register Notices & Comments

Did the Agency receive public comments on this ICR? No

---

Number of Information Collection (IC) in this ICR: 1

IC Title	Form No.	Form Name
CREDIT FOR INCREASING RESEARCH ACTIVITIES (OR FOR CLAIMING THE ORPHAN DRUG CREDIT)	6765

---

ICR Summary of Burden

	Total Approved	Previously Approved	Change Due to New Statute	Change Due to Agency Discretion	Change Due to Adjustment in Estimate	Change Due to Potential Violation of the PRA
Annual Number of Responses	15,000	17,000	0	-2,000	0	0
Annual Time Burden (Hours)	19,099	19,565	0	-466	0	0
Annual Cost Burden (Dollars)	0	0	0	0	0	0

Burden increases because of Program Change due to Agency Discretion: No

Burden Increase Due to:

Burden decreases because of Program Change due to Agency Discretion: Yes

Burden Reduction Due to:

Short Statement:

---

Annual Cost to Federal Government: $0

Does this IC contain surveys, censuses, or employ statistical methods? No

Is the Supporting Statement intended to be a Privacy Impact Assessment required by the E-Government Act of 2002? No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? Uncollected

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? Uncollected

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? Uncollected

Is this ICR related to the Pandemic Response? Uncollected

---

Common Form ICR:  No

---

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).

The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:

(a) It is necessary for the proper performance of agency functions;

(b) It avoids unnecessary duplication;

(c) It reduces burden on small entities;

(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;

(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;

(f) It indicates the retention periods for recordkeeping requirements;

(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:

(i) Why the information is being collected;

(ii) Use of information;

(iii) Burden estimate;

(iv) Nature of response (voluntary, required for a benefit, or mandatory);

(v) Nature and extent of confidentiality; and

(vi) Need to display currently valid OMB control number;

(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.

(i) It uses effective and efficient statistical survey methodology (if applicable); and

(j) It makes appropriate use of information technology.

If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.

Certification Date: 08/20/1987

---